研究增长分化因子-15作为动脉样硬化血管疾病患者炎症生物标志物的作用
Journal of vascular research
|September 4, 2025
概括
增长分化因子15 (GDF-15) 是动脉样硬化血管疾病的一个有前途的生物标志物,患者的水平明显高于健康人群. 互白素-6 (IL-6) 没有显示出类似的潜在可靠指标.
科学领域:
- 心血管研究
- 生物标志物发现
- 炎症性疾病
背景情况:
- 在血管疾病的发病过程中,炎症途径至关重要.
- 越来越多的证据表明GDF-15与动脉样硬化有关.
- 了解炎症标志物有助于诊断和管理血管疾病.
研究的目的:
- 在患有动脉样硬化血管疾病的患者和健康对照者中比较循环中的GDF- 15和IL- 6水平.
- 评估GDF-15和IL-6作为动脉样硬化血管疾病的生物标志物的潜力.
- 评估这些标记在早期风险因素修改中的有用性.
主要方法:
- 对前性收集的数据进行横截面分析.
- 使用酶相关免疫吸收试验 (ELISA) 测量血清GDF-15和IL-6水平.
- 在20名血管外科手术患者和年龄相匹配的健康志愿者之间比较标记水平.
主要成果:
- 在患者 (2515 pg/ ml) 与健康对照 (1016 pg/ ml) 的血清GDF-15水平显著升高 (p< 0. 001).
- 在20名患者中,17名患者的GDF-15水平显著升高,只有一个对照患者的GDF-15水平处于极限水平.
- 虽然IL-6水平也显著不同 (p=0. 020),但只有少数患者的水平高于参考范围.
结论:
- GDF-15是动脉样硬化血管疾病的强有力的候选生物标志物,在这个群体中表现优于IL-6.
- 患者的高GDF-15水平表明其在动脉样硬化过程中的作用.
- GDF-15可能有助于更早地识别需要修改血管疾病危险因子的个体.
相关概念视频
Inflammation
55.0K
Overview
55.0K
Role of Hematopoietic Growth Factors
1.7K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.7K
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
Atherosclerosis I: Introduction
74
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
74
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Coronary Artery Disease II: Pathophysiology
33
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33


